Biotech entity
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Artificial Intelligence, the most common co-covered peer. The tracked stories average 2 original sources each. Oncology appears in 1 tracked Biotech story from March 7, 2026.
Last mentioned: Mar 7, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Artificial Intelligence, the most common co-covered peer. The tracked stories average 2 original sources each. Oncology appears in 1 tracked Biotech story from March 7, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Oncology. Shared-story counts are live from our verified record — not editorial picks.
A major breakthrough in artificial intelligence is transforming breast cancer research, enabling predictive screening and precision diagnostics. This technological shift is expected to significantly accelerate clinical trial timelines and improve patient outcomes through earlier intervention.
Oncology is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
